Cell No. : Cell Name
RCB2618 : BCL1-B20 update : 2024/08/14 |
||||
Comment | Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.). | |||
Comment from the depositor | ||||
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. | |||
Remarks | ||||
Order Form | Order Form(C-0005.pdf) MTA(C-0007.pdf) MTA(C-0007p.pdf) | |||
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | ||||
Basic information | Depositor | Fukuda, Hiroshi | ||
Year of deposit | 2007 | |||
Original cell | TKG0435 | |||
Animal | _mouse < Mammals | |||
Strain name | BALB/c | |||
Tissue | B cell leukemia | |||
Disease name | spontaneous B cell leukemia | |||
Classification | cancer | |||
History | Cell Resource Center for Biomedical Research, Tohoku University(TKG0435) | |||
Lifespan | infinite | |||
Morphology | other | |||
Cellosaurus(Expasy) | CVCL_B994 | |||
Medium | Medium List | |||
Culture type | Adherent cells | |||
Culture medium | RPMI1640 + 10% FBS | |||
Antibiotics | Free | |||
Passage method | 0.25% Trypsin | |||
Culture information | Passage ratio | 1 : 8 split | ||
SC frequency | Subculture : 1-2 times/week, Medium Renewal : 2 times/week | |||
Temperature | 37 ℃ | |||
CO2 concentration | 5 % | |||
Freeze medium | Medium + 10% DMSO | |||
Freezing method | Slow freezing | |||
Mycoplasma/Acholeplasma | (-) | |||
SSLP(mouse) | OK | |||
Isozyme | LD, NP | |||
Images | ||||
|
|
|||
Reference information | Reference | 8 | ||
User's Publication | 3 | |||
Reference |
5198 Tominaga A, Takahashi T, Kikuchi Y, Mita S, Naomi S, Harada N, Yamaguchi N, Takatsu K. Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5. J Immunol 1990 144(4):1345-52 PubMed ID: 2303708 |
5200 Hitoshi Y, Yamaguchi N, Mita S, Sonoda E, Takaki S, Tominaga A, Takatsu K. Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. J Immunol 1990 144(11):4218-25 PubMed ID: 1692859 |
5201 Murata Y1, Yamaguchi N, Hitoshi Y, Tominaga A, Takatsu K. Interleukin 5 and interleukin 3 induce serine and tyrosine phosphorylations of several cellular proteins in an interleukin 5-dependent cell line. Biochem Biophys Res Commun 1990 173(3):1102-8 PubMed ID: 2125214 DOI: 10.1016/s0006-291x(05)80899-x |
5202 Yamaguchi N, Hitoshi Y, Mita S, Hosoya Y, Murata Y, Kikuchi Y, Tominaga A, Takatsu K. Characterization of the murine interleukin 5 receptor by using a monoclonal antibody. Int Immunol 1990 2(2):181-7 PubMed ID: 2088484 DOI: 10.1093/intimm/2.2.181 |
5206 Migita M, Yamaguchi N, Katoh S, Mita S, Matsumoto R, Sonoda E, Tsuchiya H, Matsuda I, Tominaga A, Takatsu K. Elevated expression of proto-oncogenes during interleukin-5-induced growth and differentiation of murine B lineage cells. Microbiol Immunol 1990 34(11):937-52 PubMed ID: 2090920 DOI: 10.1111/j.1348-0421.1990.tb01072.x |
1985 Mita S, Tominaga A, Hitoshi Y, Sakamoto K, Honjo T, Akagi M, Kikuchi Y, Yamaguchi N, Takatsu K Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc Natl Acad Sci U S A 1989 86:2311-5 PubMed ID: 2784567 DOI: 10.1073/pnas.86.7.2311 |
4819 Mita S, Harada N, Naomi S, Hitoshi Y, Sakamoto K, Akagi M, Tominaga A, Takatsu K. Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication. J Exp Med 1988 168(3):863-78 PubMed ID: 3262707 DOI: 10.1084/jem.168.3.863 |
5199 Strober S, Gronowicz ES, Knapp MR, Slavin S, Vitetta ES, Warnke RA, Kotzin B, Schröder J. Immunobiology of a spontaneous murine B cell leukemia (BCL1). Immunol Rev 1979 48:169-95 PubMed ID: 121100 DOI: 10.1111/j.1600-065x.1979.tb00303.x |
User's Publication |
7581 Hiroi M, Sakaeda Y, Yamaguchi H, Ohmori Y. Anti-inflammatory cytokine interleukin-4 inhibits inducible nitric oxide synthase gene expression in the mouse macrophage cell line RAW264.7 through the repression of octamer-dependent transcription. Mediators Inflamm. 2013 2013:369693 PubMed ID: 24459328 DOI: 10.1155/2013/369693 |
7699 Yokoi H, Kasahara M, Mori K, Ogawa Y, Kuwabara T, Imamaki H, Kawanishi T, Koga K, Ishii A, Kato Y, Mori KP, Toda N, Ohno S, Muramatsu H, Muramatsu T, Sugawara A, Mukoyama M, Nakao K. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int. 2012 81:160-9 PubMed ID: 21881556 DOI: 10.1038/ki.2011.305 |
4847 Cho Y, Honda S, Yoshizawa Y, Takagaki K, Usui K, Shibuya A. Requirement of the cytoplasmic portion for dimer formation of Fcalpha/micro receptor expressed on cell surface. Mol Immunol 2010 47(4):878-82 PubMed ID: 19945166 DOI: 10.1016/j.molimm.2009.10.016 |